You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 3, March 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Pediatrics
 •Congenital Malformations
 •Diagnosis
 •Vascular Malformations
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Misnomer "Macrocephaly–Cutis Marmorata Telangiectatica Congenita Syndrome"

Report of 12 New Cases and Support for Revising the Name to Macrocephaly–Capillary Malformations

Dakara Rucker Wright, MD; Ilona J. Frieden, MD; Seth J. Orlow, MD, PhD; Helen T. Shin, MD; Sarah Chamlin, MD; Julie V. Schaffer, MD; Amy S. Paller, MD

Arch Dermatol. 2009;145(3):287-293.

Background  The condition known as macrocephaly–cutis marmorata telangiectatica congenita syndrome (M-CMTC) is a rare congenital syndrome of unknown etiology characterized by macrocephaly and vascular lesions that have been described as either cutis marmorata or cutis marmorata telangiectatica congenita (CMTC). Most patients also exhibit facial and limb asymmetry; somatic overgrowth; developmental delay; capillary malformations of the nose, philtrum, and/or upper lip; neurologic abnormalities; syndactyly or polydactyly; craniofacial abnormalities; and joint laxity or soft skin.

Observations  We describe 12 patients with this condition from tertiary care medical centers (8 cases) and accrued via an M-CMTC support group Web site (4 cases). All patients showed reticulated or confluent port-wine stains (PWS), not CMTC. Seven of the 12 patients also had centrofacial capillary malformations. In our comprehensive review of 100 previously reported cases, only 34 were accompanied by photographs that were sufficiently clear to review for diagnostic purposes. None had true CMTC, with most having reticulated PWS or persistent cutis marmorata.

Conclusions  Reticulated or confluent PWS and persistent capillary malformations of the central face, rather than CMTC, are the most characteristic cutaneous vascular anomalies seen in so-called M-CMTC syndrome. The name macrocephaly–capillary malformations (M-CM) more accurately reflects the features of this syndrome.


Author Affiliations: Department of Dermatology, Henry Ford Hospital, Detroit, Michigan (Dr Wright); Department of Dermatology and Pediatrics, University of California, San Francisco (Dr Frieden); Department of Dermatology, New York University Medical Center, New York (Drs Orlow and Schaffer); Department of Pediatric Dermatology, Hackensack University Medical Center, Hackensack, New Jersey (Dr Shin); and Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Drs Wright, Chamlin, and Paller).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Dermatology
Arch Dermatol. 2009;145(3):239.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Macrocephaly-Capillary Malformation Syndrome Is Accurate. Goodbye, M-CMTC
Journal Watch Dermatology 2009;2009:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.